• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻素受体激动剂花生四烯乙醇胺的酶促合成与降解

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist.

作者信息

Deutsch D G, Chin S A

机构信息

Department of Biochemistry and Cell Biology, State University of New York at Stony Brook, NY 11794.

出版信息

Biochem Pharmacol. 1993 Sep 1;46(5):791-6. doi: 10.1016/0006-2952(93)90486-g.

DOI:10.1016/0006-2952(93)90486-g
PMID:8373432
Abstract

Enzymatic activities have been identified which catalyze both the hydrolysis and synthesis of arachidonylethanolamide (anandamide). Anandamide was taken up by neuroblastoma and glioma cells in culture, but it did not accumulate since it was rapidly degraded by an amidase activity that resided mainly in the membrane fractions. This amidase activity was expressed in brain and the majority of cells and tissues tested. Phenylmethylsulfonyl fluoride (PMSF) was found to be a potent inhibitor of this amidase. A catalytic activity for the biosynthesis of anandamide from ethanolamine and arachidonic acid was readily apparent in incubations of rat brain homogenates. The stability of anandamide in serum and its rapid breakdown in cells and tissues are consistent with the observation that it is active when administered systemically, and its duration of action will be regulated by its rate of degradation in cells.

摘要

已经鉴定出催化花生四烯酸乙醇酰胺(阿南达米德)水解和合成的酶活性。阿南达米德被培养中的神经母细胞瘤和胶质瘤细胞摄取,但由于它被主要存在于膜组分中的酰胺酶活性迅速降解,所以并未积累。这种酰胺酶活性在脑以及大多数测试的细胞和组织中都有表达。发现苯甲基磺酰氟(PMSF)是这种酰胺酶的有效抑制剂。在大鼠脑匀浆孵育中,从乙醇胺和花生四烯酸生物合成阿南达米德的催化活性很明显。阿南达米德在血清中的稳定性及其在细胞和组织中的快速分解与以下观察结果一致:它在全身给药时具有活性,其作用持续时间将由其在细胞中的降解速率调节。

相似文献

1
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist.大麻素受体激动剂花生四烯乙醇胺的酶促合成与降解
Biochem Pharmacol. 1993 Sep 1;46(5):791-6. doi: 10.1016/0006-2952(93)90486-g.
2
Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.脂肪酸磺酰氟抑制花生四烯乙醇胺代谢并与大麻素受体结合。
Biochem Biophys Res Commun. 1997 Feb 3;231(1):217-21. doi: 10.1006/bbrc.1997.6072.
3
Effects of anandamide on cannabinoid receptors in rat brain membranes.
Biochem Pharmacol. 1994 Feb 11;47(4):711-5. doi: 10.1016/0006-2952(94)90134-1.
4
Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.花生四烯乙醇胺,一种内源性大麻素样类二十烷酸,与克隆的人类大麻素受体结合并刺激受体介导的信号转导。
Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7656-60. doi: 10.1073/pnas.90.16.7656.
5
The binding of novel phenolic derivatives of anandamide to brain cannabinoid receptors.
Prostaglandins Leukot Essent Fatty Acids. 1995 Feb-Mar;52(2-3):83-6. doi: 10.1016/0952-3278(95)90002-0.
6
Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase.花生四烯酸乙醇胺,一种脑内源性化合物,与大麻素受体特异性相互作用并抑制腺苷酸环化酶。
J Neurochem. 1993 Jul;61(1):352-5. doi: 10.1111/j.1471-4159.1993.tb03576.x.
7
Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand.与另一种大麻素受体配体2-花生四烯酸甘油酯发生反应的花生四烯乙醇胺酰胺水解酶。
FEBS Lett. 1998 Jan 23;422(1):69-73. doi: 10.1016/s0014-5793(97)01603-7.
8
Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.大麻素受体激动剂花生四烯乙醇胺(一种脑内成分)的药理活性。
Eur J Pharmacol. 1993 Feb 9;231(2):313-4. doi: 10.1016/0014-2999(93)90468-w.
9
Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells.花生四烯乙醇胺,一种内源性大麻素,在N18神经母细胞瘤细胞中作为部分激动剂抑制钙电流。
Mol Pharmacol. 1993 Sep;44(3):498-503.
10
A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors.一种使大麻素受体的内源性配体失活的水解酶。
J Med Invest. 1998 Aug;45(1-4):27-36.

引用本文的文献

1
Cannabinoids and the endocannabinoid system in the regulation of cytochrome P450 metabolic activity-a review.大麻素与内源性大麻素系统对细胞色素P450代谢活性的调节——综述
Front Pharmacol. 2025 Jun 5;16:1599012. doi: 10.3389/fphar.2025.1599012. eCollection 2025.
2
Molecular Fingerprint of Endocannabinoid Signaling in the Developing Paraventricular Nucleus of the Hypothalamus as Revealed by Single-Cell RNA-Seq and In Situ Hybridization.单细胞RNA测序和原位杂交揭示的下丘脑室旁核发育过程中内源性大麻素信号的分子指纹
Cells. 2025 May 27;14(11):788. doi: 10.3390/cells14110788.
3
LY-2183240 enhances reward-seeking behavior with inducing neuronal excitation and early apoptosis in mouse.
LY-2183240通过诱导小鼠神经元兴奋和早期凋亡来增强奖赏寻求行为。
iScience. 2024 Sep 30;27(11):111069. doi: 10.1016/j.isci.2024.111069. eCollection 2024 Nov 15.
4
Associations between methamphetamine use disorder and , , , and gene sequence variants and expression levels.与 、 、 、 和 基因序列变异和表达水平相关的甲基苯丙胺使用障碍的关联。
Dialogues Clin Neurosci. 2024;26(1):64-76. doi: 10.1080/19585969.2024.2413476. Epub 2024 Oct 12.
5
Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density.可卡因依赖患者血浆内源性大麻素及其与脑代谢型谷氨酸受体 5 密度的关系。
Transl Psychiatry. 2023 Oct 19;13(1):325. doi: 10.1038/s41398-023-02628-7.
6
Molecular basis of FAAH-OUT-associated human pain insensitivity.FAAH-OUT 相关人类痛觉不敏感的分子基础。
Brain. 2023 Sep 1;146(9):3851-3865. doi: 10.1093/brain/awad098.
7
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years.内源性大麻素系统作为治疗靶点的利弊:30 年的经验教训。
Pharmacol Rev. 2023 Sep;75(5):885-958. doi: 10.1124/pharmrev.122.000600. Epub 2023 May 10.
8
The Endocannabinoid System as a Target for Neuroprotection/Neuroregeneration in Perinatal Hypoxic-Ischemic Brain Injury.内源性大麻素系统作为围产期缺氧缺血性脑损伤中神经保护/神经再生的靶点
Biomedicines. 2022 Dec 22;11(1):28. doi: 10.3390/biomedicines11010028.
9
Altered endocannabinoid metabolism compromises the brain-CSF barrier and exacerbates chronic deficits after traumatic brain injury in mice.内源性大麻素代谢改变破坏血脑屏障,并使创伤性脑损伤后小鼠的慢性缺损恶化。
Exp Neurol. 2023 Mar;361:114320. doi: 10.1016/j.expneurol.2023.114320. Epub 2023 Jan 7.
10
Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases.大麻素化合物作为治疗非癌症皮肤疾病的一种药物治疗选择。
Cells. 2022 Dec 16;11(24):4102. doi: 10.3390/cells11244102.